Skip to main content
. 2020 Feb 7;38(14):1518–1526. doi: 10.1200/JCO.19.02408

FIG 1.

FIG 1.

(A) Transplantation-related mortality. The 4-year cumulative incidence of transplantation-related mortality was 20% (95% CI, 16% to 24%) for haploidentical bone marrow (BM) transplantations, 18% (95% CI, 12% to 25%) for haploidentical peripheral-blood (PB) transplantations, and 33% (95% CI, 27% to 40%) for unrelated cord blood (UCB) transplantations. (B) Relapse or progression. The 4-year cumulative incidence of relapse or progression was 34% (95% CI, 29% to 39%) for haploidentical BM transplantations, 30% (95% CI, 22% to 38%) for haploidentical PB transplantations, and 31% (95% CI, 25% to 37%) for UCB transplantations. Haplo, haploidentical.